Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5 USD | -1.48% | -35.82% | +12.11% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
Financials (USD)
Sales 2024 * | 68.34M | Sales 2025 * | 84.72M | Capitalization | 774M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -108M | EV / Sales 2024 * | 11.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 9.13 x |
P/E ratio 2024 * |
-5.82
x | P/E ratio 2025 * |
-5.9
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.32% |
Latest transcript on Ocular Therapeutix, Inc.
1 day | -1.48% | ||
1 week | -34.04% | ||
Current month | -45.05% | ||
1 month | -46.87% | ||
3 months | +24.69% | ||
6 months | +104.08% | ||
Current year | +12.11% |
Managers | Title | Age | Since |
---|---|---|---|
Donald Notman
DFI | Director of Finance/CFO | 64 | 17-09-24 |
Chief Tech/Sci/R&D Officer | - | 21-09-27 | |
Rabia Ozden
CTO | Chief Tech/Sci/R&D Officer | 56 | 21-01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 23-07-09 |
Director/Board Member | 76 | 12-11-04 | |
Merilee Raines
BRD | Director/Board Member | 68 | 21-09-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +5.94% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 5 | -1.48% | 2,276,166 |
24-04-22 | 5.075 | -2.78% | 3,745,815 |
24-04-19 | 5.22 | -10.92% | 9,125,811 |
24-04-18 | 5.86 | -22.69% | 6,074,050 |
24-04-17 | 7.58 | -2.70% | 983,500 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.11% | 785M | |
+27.92% | 659B | |
+27.68% | 557B | |
-4.59% | 359B | |
+16.38% | 322B | |
+9.39% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.58% | 149B |
- Stock Market
- Equities
- OCUL Stock